With its 108th scientific assembly and annual meeting a little more than two weeks away, the Radiological Society of North America is encouraging attendees to experience 2022’s big show virtually—even if they’ll be there in person.

RapidAI has been cleared for U.S. marketing of updated AI-outfitted software that quickly detects or rules out acute brain hemorrhage on unenhanced CT.

Insilico Medicine, a clinical stage AI-drive drug discovery company, has penned a multi-year, multi-target strategic research collaboration with Sanofi in a deal valued at $1.2 billion.

The new study, presented at the AHA Scientific Sessions 2022 conference in Chicago, focused on data from more than 2,000 patients. 

In a new paper in Radiology, experts explain how the use of artificial intelligence to identify lesion subtypes could benefit both clinics and patients. 

New research out of Mayo Clinic found that clinicians who listened to AI-based treatment recommendations were more successful at identifying patients with low ejection fraction. 

When implanted in the brain, the chips can lessen symptoms by modulating abnormal brain activity.

The model could be beneficial for long COVID patients in areas where CT scans are not readily available, researchers concluded.